106 related articles for article (PubMed ID: 22273635)
1. Clinical importance of hypothyroxinemia in the preterm infant and a discussion of treatment concerns.
La Gamma EF; Paneth N
Curr Opin Pediatr; 2012 Apr; 24(2):172-80. PubMed ID: 22273635
[TBL] [Abstract][Full Text] [Related]
2. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age.
Reuss ML; Paneth N; Pinto-Martin JA; Lorenz JM; Susser M
N Engl J Med; 1996 Mar; 334(13):821-7. PubMed ID: 8596548
[TBL] [Abstract][Full Text] [Related]
3. Thyroxine for transient hypothyroxinemia and cerebral palsy in extremely preterm infants.
Suzumura H; Nitta A; Tsuboi Y; Watabe Y; Kuribayashi R; Arisaka O
Pediatr Int; 2011 Aug; 53(4):463-7. PubMed ID: 21054676
[TBL] [Abstract][Full Text] [Related]
4. Perinatal factors affecting thyroid hormone status in extreme preterm infants.
Williams FL; Hume R
Semin Perinatol; 2008 Dec; 32(6):398-402. PubMed ID: 19007676
[TBL] [Abstract][Full Text] [Related]
5. Phase 1 trial of 4 thyroid hormone regimens for transient hypothyroxinemia in neonates of <28 weeks' gestation.
La Gamma EF; van Wassenaer AG; Ares S; Golombek SG; Kok JH; Quero J; Hong T; Rahbar MH; de Escobar GM; Fisher DA; Paneth N
Pediatrics; 2009 Aug; 124(2):e258-68. PubMed ID: 19581264
[TBL] [Abstract][Full Text] [Related]
6. Maternal and infant thyroid disorders and cerebral palsy.
Hong T; Paneth N
Semin Perinatol; 2008 Dec; 32(6):438-45. PubMed ID: 19007683
[TBL] [Abstract][Full Text] [Related]
7. Serum thyroid hormone levels in preterm infants born before 33 weeks of gestation and association of transient hypothyroxinemia with postnatal characteristics.
Dilli D; Oğuz SS; Andiran N; Dilmen U; Büyükkağnici U
J Pediatr Endocrinol Metab; 2010 Sep; 23(9):899-912. PubMed ID: 21175089
[TBL] [Abstract][Full Text] [Related]
8. Effect of l-thyroxine supplementation on infants with transient hypothyroxinemia of prematurity at 18 months of corrected age: randomized clinical trial.
Uchiyama A; Kushima R; Watanabe T; Kusuda S
J Pediatr Endocrinol Metab; 2015 Jan; 28(1-2):177-82. PubMed ID: 25153575
[TBL] [Abstract][Full Text] [Related]
9. The influence of amino-acid supplementation, gestational age and time on thyroxine levels in premature neonates.
Kelleher AS; Clark RH; Steinbach M; Chace DH; Spitzer AR;
J Perinatol; 2008 Apr; 28(4):270-4. PubMed ID: 18288119
[TBL] [Abstract][Full Text] [Related]
10. Treatment of transient hypothyroxinemia of prematurity: a survey of neonatal practice.
Golombek SG; LaGamma EF; Paneth N
J Perinatol; 2002; 22(7):563-5. PubMed ID: 12368973
[TBL] [Abstract][Full Text] [Related]
11. Thyroid system immaturities in very low birth weight premature infants.
Fisher DA
Semin Perinatol; 2008 Dec; 32(6):387-97. PubMed ID: 19007675
[TBL] [Abstract][Full Text] [Related]
12. Neurodevelopmental outcome at 5 years of age of a national cohort of extremely low birth weight infants who were born in 1996-1997.
Mikkola K; Ritari N; Tommiska V; Salokorpi T; Lehtonen L; Tammela O; Pääkkönen L; Olsen P; Korkman M; Fellman V
Pediatrics; 2005 Dec; 116(6):1391-400. PubMed ID: 16322163
[TBL] [Abstract][Full Text] [Related]
13. Grades I-II intraventricular hemorrhage in extremely low birth weight infants: effects on neurodevelopment.
Patra K; Wilson-Costello D; Taylor HG; Mercuri-Minich N; Hack M
J Pediatr; 2006 Aug; 149(2):169-73. PubMed ID: 16887428
[TBL] [Abstract][Full Text] [Related]
14. Changes in neurodevelopmental outcome at age eight in geographic cohorts of children born at 22-27 weeks' gestational age during the 1990s.
Roberts G; Anderson PJ; De Luca C; Doyle LW;
Arch Dis Child Fetal Neonatal Ed; 2010 Mar; 95(2):F90-4. PubMed ID: 19846389
[TBL] [Abstract][Full Text] [Related]
15. The relationship between thyroxine level and short term clinical outcome among sick newborn infants.
Kadivar M; Parsaei R; Setoudeh A
Acta Med Iran; 2011; 49(2):93-7. PubMed ID: 21598217
[TBL] [Abstract][Full Text] [Related]
16. Changes in neurodevelopmental outcomes at 18 to 22 months' corrected age among infants of less than 25 weeks' gestational age born in 1993-1999.
Hintz SR; Kendrick DE; Vohr BR; Poole WK; Higgins RD;
Pediatrics; 2005 Jun; 115(6):1645-51. PubMed ID: 15930228
[TBL] [Abstract][Full Text] [Related]
17. Levels of neonatal thyroid hormone in preterm infants and neurodevelopmental outcome at 5 1/2 years: millennium cohort study.
Delahunty C; Falconer S; Hume R; Jackson L; Midgley P; Mirfield M; Ogston S; Perra O; Simpson J; Watson J; Willatts P; Williams F;
J Clin Endocrinol Metab; 2010 Nov; 95(11):4898-908. PubMed ID: 20719832
[TBL] [Abstract][Full Text] [Related]
18. Impact of the use of antenatal corticosteroids on mortality, cerebral lesions and 5-year neurodevelopmental outcomes of very preterm infants: the EPIPAGE cohort study.
Foix-L'Hélias L; Marret S; Ancel PY; Marchand L; Arnaud C; Fresson J; Picaud JC; Rozé JC; Theret B; Burguet A; Larroque B; Kaminski M;
BJOG; 2008 Jan; 115(2):275-82. PubMed ID: 18081606
[TBL] [Abstract][Full Text] [Related]
19. Measuring functional outcomes after prematurity: developmental impact of very low birth weight and extremely low birth weight status on childhood disability.
Msall ME; Tremont MR
Ment Retard Dev Disabil Res Rev; 2002; 8(4):258-72. PubMed ID: 12454902
[TBL] [Abstract][Full Text] [Related]
20. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation.
van Wassenaer AG; Kok JH; de Vijlder JJ; Briët JM; Smit BJ; Tamminga P; van Baar A; Dekker FW; Vulsma T
N Engl J Med; 1997 Jan; 336(1):21-6. PubMed ID: 8970936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
